Literature DB >> 11961075

Relative reinforcing effects of three opioids with different durations of action.

M C Ko1, J Terner, S Hursh, J H Woods, G Winger.   

Abstract

The role of duration of action on the relative reinforcing effects of three opioid drugs (fentanyl, alfentanil, and remifentanil) was evaluated. Duration and onset of action were determined using measures of respiratory depression and antinociception after i.v. administration. Effects on minute volume of respiration indicated that each of the three opioids had immediate onsets of action after i.v. administration. Fentanyl's duration of suppression of respiration and antinociception was longer than that of alfentanil, which was longer than that of remifentanil. Reinforcing strength was measured in i.v. self-administration studies in which the fixed ratio resulting in drug administration was increased from one session to the next. Comparisons were made of the behavioral economic variables P(max) and area under the demand curve (O(max)). Remifentanil maintained higher rates of responding than did alfentanil, and alfentanil maintained higher rates of responding than did fentanyl. When normalized demand functions were compared, however, the drugs did not differ significantly from each other in terms of P(max) or O(max). These data agree with those of others who have suggested that duration of action is not an important contributor to drugs' reinforcing strength.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961075     DOI: 10.1124/jpet.301.2.698

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  52 in total

1.  Assessing unit-price related remifentanil choice in rhesus monkeys.

Authors:  Chad M Galuska; Gail Winger; Steven R Hursh; James H Woods
Journal:  J Exp Anal Behav       Date:  2006-09       Impact factor: 2.468

2.  Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys.

Authors:  Heather L Kimmel; Joann A O'Connor; F Ivy Carroll; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2006-12-20       Impact factor: 3.533

3.  Tests of behavioral-economic assessments of relative reinforcer efficacy II: economic complements.

Authors:  Gregory J Madden; John R Smethells; Eric E Ewan; Steven R Hursh
Journal:  J Exp Anal Behav       Date:  2007-11       Impact factor: 2.468

4.  Tests of behavioral-economic assessments of relative reinforcer efficacy: economic substitutes.

Authors:  Gregory J Madden; John R Smethells; Eric E Ewan; Steven R Hursh
Journal:  J Exp Anal Behav       Date:  2007-03       Impact factor: 2.468

5.  Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.

Authors:  David R Maguire; Lisa R Gerak; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

6.  The effects of session length on demand functions generated using FR schedules.

Authors:  T Mary Foster; Jennifer Kinloch; Alan Poling
Journal:  J Exp Anal Behav       Date:  2011-05       Impact factor: 2.468

7.  Demand curves for hypothetical cocaine in cocaine-dependent individuals.

Authors:  Natalie R Bruner; Matthew W Johnson
Journal:  Psychopharmacology (Berl)       Date:  2013-11-12       Impact factor: 4.530

8.  Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys.

Authors:  Peter F Weed; Charles P France; Lisa R Gerak
Journal:  J Pharmacol Exp Ther       Date:  2017-04-24       Impact factor: 4.030

Review 9.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

10.  A stimulus-control account of regulated drug intake in rats.

Authors:  Leigh V Panlilio; Eric B Thorndike; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2007-10-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.